Stay updated on Expanded Access to Upadacitinib Clinical Trial
Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.4.2 has been added, and the previous Notice about a lapse in government funding (Revision: v3.4.1) has been removed. These updates are administrative and do not affect the core study information or accessibility of the expanded access program. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedNew government funding status notice is displayed at the top of the page. The Eligibility section was updated with new Exclusion Criteria (There are other suitable treatment options; the participant qualifies for ongoing clinical trials) and a previously listed Inclusion Criteria item was removed.SummaryDifference1%

- Check28 days agoChange DetectedChanges are limited to page metadata and UI labels, including a glossary toggle, updated QC-related fields (Last Update Submitted that Met QC Criteria, Last Update Posted), a No FEAR Act notice, and a revision to version 3.4.0, with older QC labeling and v3.3.4 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedMinor version update from v3.3.3 to v3.3.4 detected; page content and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updated to show Revision: v3.3.3, with HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision history shows a new entry v3.3.2 and removal of v3.2.0. No substantive study content or eligibility details were changed.SummaryDifference0.1%

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.